These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26176734)

  • 1. Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2.
    Zheng X; Chen S; Yang Q; Cai J; Zhang W; You H; Xing J; Dong Y
    Cancer Biol Ther; 2015; 16(9):1407-14. PubMed ID: 26176734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvianolic acid A reverses paclitaxel resistance in human breast cancer MCF-7 cells via targeting the expression of transgelin 2 and attenuating PI3 K/Akt pathway.
    Cai J; Chen S; Zhang W; Zheng X; Hu S; Pang C; Lu J; Xing J; Dong Y
    Phytomedicine; 2014 Oct; 21(12):1725-32. PubMed ID: 25442283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
    Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y
    Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
    Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
    Int J Oncol; 2017 Mar; 50(3):893-902. PubMed ID: 28197640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.
    Chen S; Dong Q; Hu S; Cai J; Zhang W; Sun J; Wang T; Xie J; He H; Xing J; Lu J; Dong Y
    Mol Biosyst; 2014 Feb; 10(2):294-303. PubMed ID: 24292090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreducible and acid-labile polydiethylenetriamines with sequential degradability for efficient transgelin-2 siRNA delivery.
    Wang P; Yan Y; Sun Y; Zhang R; Huo C; Li L; Wang K; Dong Y; Xing J
    J Mater Chem B; 2019 Nov; 7(44):6994-7005. PubMed ID: 31625545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgelin 2 Promotes Paclitaxel Resistance, Migration, and Invasion of Breast Cancer by Directly Interacting with PTEN and Activating PI3K/Akt/GSK-3β Pathway.
    Liu L; Meng T; Zheng X; Liu Y; Hao R; Yan Y; Chen S; You H; Xing J; Dong Y
    Mol Cancer Ther; 2019 Dec; 18(12):2457-2468. PubMed ID: 31488699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1.
    Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T
    Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgelin Silencing Induces Different Processes in Different Breast Cancer Cell Lines.
    Dvorakova M; Lapcik P; Bouchalova P; Bouchal P
    Proteomics; 2020 Apr; 20(7):e1900383. PubMed ID: 32061197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
    Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
    Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway.
    Zhang W; Cai J; Chen S; Zheng X; Hu S; Dong W; Lu J; Xing J; Dong Y
    Mol Med Rep; 2015 Jul; 12(1):1506-14. PubMed ID: 25760096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer.
    Ji X; Peng Z; Li X; Yan Z; Yang Y; Qiao Z; Liu Y
    Cancer Lett; 2017 Feb; 386():24-34. PubMed ID: 27832973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of paclitaxel-resistant breast cancer cell line and nude mice models, and underlying multidrug resistance mechanisms in vitro and in vivo.
    Chen SY; Hu SS; Dong Q; Cai JX; Zhang WP; Sun JY; Wang TT; Xie J; He HR; Xing JF; Lu J; Dong YL
    Asian Pac J Cancer Prev; 2013; 14(10):6135-40. PubMed ID: 24289639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells.
    Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
    Int J Cancer; 2009 Dec; 125(12):2820-8. PubMed ID: 19551867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid A shows selective cytotoxicity against multidrug-resistant MCF-7 breast cancer cells.
    Wang X; Wang C; Zhang L; Li Y; Wang S; Wang J; Yuan C; Niu J; Wang C; Lu G
    Anticancer Drugs; 2015 Feb; 26(2):210-23. PubMed ID: 25419632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction.
    Zhong W; Sun B; Gao W; Qin Y; Zhang H; Huai L; Tang Y; Liang Y; He L; Zhang X; Tao H; Chen S; Yang W; Yang L; Liu Y; Liu H; Zhou H; Sun T; Yang C
    EBioMedicine; 2018 Nov; 37():246-258. PubMed ID: 30361065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
    Li X; Han X; Wei P; Yang J; Sun J
    Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles.
    Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y
    Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis.
    Xue YN; Yu BB; Liu YN; Guo R; Li JL; Zhang LC; Su J; Sun LK; Li Y
    Prostate; 2019 May; 79(6):647-656. PubMed ID: 30714183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.